Has the rescheduling of modified‐release paracetamol in Australia affected the frequency of overdoses?
Emergency Medicine Australasia · 2024
DOI: 10.1111/1742-6723.14403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emergency Medicine Australasia, 2024. Verfasst von Michaela J Ryan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Acetaminophen, Drug Overdose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
In June 2020, modified‐release paracetamol (paracetamol‐MR) preparations were up‐scheduled from schedule‐2 (available in pharmacy) to schedule‐3 (available by request to a pharmacist only). The present study aims to ascertain whether up‐scheduling affected the frequency of paracetamol‐MR overdoses.
Methods
This is a retrospective cohort study of two data sets from 1 June 2017 to 31 May 2022. Monash Health data were extracted using the diagnosis of paracetamol overdose coding and electronic medical records data. Calls regarding paracetamol‐MR overdoses to Victorian Poisons Information Centre (VPIC) were extracted from the Poisons centre call database. We used a quasi‐experimental research design with interrupted time series analysis to evaluate the immediate impact and change in trend of poisoning‐related calls and ED presentations before and after June 2020. The change in proportion of paracetamol‐MR cases in both databases was analysed using the Χ 2 test.
Results
The proportion of paracetamol‐MR cases in both data sets did not change. From Monash Health, there was no level change in monthly paracetamol‐MR overdose‐related presentations following re‐scheduling (rate ratio [RR] = 1.08, 95% confidence interval [CI] = 0.57–2.01). There was no change in monthly paracetamol‐MR overdose‐related calls to VPIC following re‐scheduling (RR = 1.05, 95% CI = 0.96–1.14).
Conclusion
The proportion of paracetamol‐MR overdoses did not decrease after the up‐scheduling to S3. Similarly, the frequency of overdoses by month remained similar. Further limitations on access to paracetamol products may need to be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.
- Monash Toxicology Unit and Emergency Department, Dandenong Hospital, Monash Health, Melbourne, Victoria, Australia.
- Victorian Poisons Information Centre, Austin Health, Melbourne, Victoria, Australia.
- Translational Australian Clinical Toxicology, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Michaela J Ryan, Andis Graudins, Nicole O'Shea, Firouzeh Noghrehchi, Anselm Wong
Zitieren
APA
Ryan, M. J., Graudins, A., O'Shea, N., Noghrehchi, F., & Wong, A. (2024). Has the rescheduling of modified‐release paracetamol in Australia affected the frequency of overdoses?. Emergency Medicine Australasia. https://doi.org/10.1111/1742-6723.14403
Vancouver
Ryan MJ, Graudins A, O'Shea N, Noghrehchi F, Wong A. Has the rescheduling of modified‐release paracetamol in Australia affected the frequency of overdoses?. Emergency Medicine Australasia. 2024. doi:10.1111/1742-6723.14403
BibTeX
@article{Ryan2024,
author = {Ryan, Michaela J and Graudins, Andis and O'Shea, Nicole and Noghrehchi, Firouzeh and Wong, Anselm},
title = {Has the rescheduling of modified‐release paracetamol in Australia affected the frequency of overdoses?},
journal = {Emergency Medicine Australasia},
year = {2024},
doi = {10.1111/1742-6723.14403}
}
EUVIMED